MTOR and cancer: Fatostatin, Betulin, and Xanthohumol have been shown to suppress cancer progression not only via the SCAP-SREBP pathway but also through inhibition of mTOR, MAPK, and Notch signaling (Kunnimalaiyaan et al., 2015; Han et al., 2019; Cai et al., 2023).